Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0000950170-25-017031

Director bought 550,000 shares at $18.00 ($9,900,000)

  • Director acquired 3,154,959 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Peter A. Director 2025-02-10 Conversion +3,154,959 3,154,959 I
Thompson Peter A. Director 2025-02-10 Purchase +550,000 $18.00 $9,900,000 3,704,959 I
Derivatives
Thompson Peter A. Director 2025-02-10 Conversion · Series B convertible preferred stock −2,560,951 0 I
Thompson Peter A. Director 2025-02-10 Conversion · Series C convertible preferred stock −2,048,760 0 I
Open-market purchases · 550,000 sh · avg $18.00 · $9,900,000
Loading xslF345X05/ownership.xml…